(Q44009660)

28 November 2017

title

Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone (English)

1 reference

28 November 2017

1 reference

1 reference

1 reference

J C Xiu

1

1 reference

28 November 2017

P Wu

2

1 reference

28 November 2017

J P Xu

3

1 reference

28 November 2017

Z Guo

4

1 reference

28 November 2017

W Lai

5

1 reference

28 November 2017

Y Zhang

6

1 reference

28 November 2017

S Li

7

1 reference

28 November 2017

J Li

8

1 reference

28 November 2017

Y Liu

9

1 reference

28 November 2017

publication date

1 May 2002

1 reference

Journal of Endocrinological Investigation

28 November 2017

published in

1 reference

28 November 2017

volume

25

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

463-468

1 reference

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

Myocardial infarct size and ventricular function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

Participation of vascular prostacyclin for the pathogenesis of experimental glucocorticoid hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

An improved perfusion apparatus for small animal hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

Enalapril induces regression of cardiac hypertrophy and normalization of pHi regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03344039

Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats

21 January 2018

1 reference

12 December 2020

Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation

1 reference

12 December 2020

Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors

1 reference

12 December 2020

[The antihypertensive activity of benazepril in the long-term treatment of hypertension patients and its effect on adrenal cortical function]

1 reference

12 December 2020

Aldosterone biosynthesis and action in vascular cells

1 reference

12 December 2020

Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy

1 reference

12 December 2020

Effects of cholic acid on blood pressure and production of vascular aldosterone and corticosterone

1 reference

12 December 2020

Angiotensin II-receptor antagonists: an overview.

1 reference

12 December 2020

The role of angiotensin II receptors and their antagonists in hypertension

1 reference

12 December 2020

Cardiac aldosterone production in genetically hypertensive rats

1 reference

12 December 2020

Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis

1 reference

12 December 2020

Determinants of cardiac fibrosis in experimental hypermineralocorticoid states

1 reference

12 December 2020

Hypertensive cardiomegaly caused by an aldosterone-secreting adenoma in a newborn

1 reference

12 December 2020

Differences in tissue angiotensin II-forming pathways by species and organs in vitro

1 reference

12 December 2020

Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan

1 reference

12 December 2020

Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients

1 reference

12 December 2020

AT1-receptor antagonists for the treatment of chronic heart failure

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03344039

1 reference

28 November 2017

1 reference